Both in Biotechnology
VivoSim Labs vs AIM ImmunoTech
Over the past year VIVS returned −93.1% and AIM returned −89.9%; their daily moves had a correlation of 0.10.
VIVS −93.1% AIM −89.9%Growth of $1, one year, split-adjusted
| Metric | VIVS | AIM |
|---|---|---|
| Price | $0.1522 | $0.1610 |
| Market cap | $2.0M | $6.4M |
| Today | +5.99% | +0.19% |
| 1 month | −24.6% | −11.8% |
| 6 months | −89.2% | −66.5% |
| Year to date | −91.6% | −85.7% |
| 1 year | −93.6% | −92.0% |
| Revenue growth (YoY) | −51.4% | +4.0% |
| Gross margin | 100.0% | 80.8% |
| Net margin | −7433.3% | −26876.9% |
| P/E (TTM) | — | — |
| Price / sales | 18.2× | 67.6× |
| Net cash | $1.7M | $6.3M |
| Dividend yield | — | — |
| Volatility (60d) | 77.2% | 67.9% |
| Short % of float | 4.0% | 3.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).